Cargando…

Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves’ disease

PURPOSE: Thyrotropin receptor (TSHR) autoantibodies (TRAbs) are a hallmark of Graves’ disease (GD). The aim of this study was to evaluate the diagnostic accuracy of a new third generation automatic fluorescence enzyme immunoassay for TRAb measurement in GD, in comparison with two current IMAs. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villalta, Danilo, D’Aurizio, Federica, Da Re, Mirella, Ricci, Debora, Latrofa, Francesco, Tozzoli, Renato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809681/ https://www.ncbi.nlm.nih.gov/pubmed/29435670 http://dx.doi.org/10.1007/s13317-018-0102-4

Ejemplares similares

Automation, consolidation, and integration in autoimmune diagnostics
por: Tozzoli, Renato, et al.
Publicado: (2015)

Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods
por: D’Aurizio, Federica, et al.
Publicado: (2015)

Accuracy of receptor-based methods for detection of thyrotropin-receptor autoantibodies: a new automated third-generation immunoassay shows higher analytical and clinical sensitivity for the differential diagnosis of hyperthyroidism
por: Tozzoli, Renato, et al.
Publicado: (2010)

Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab
por: Serrier, Julien, et al.
Publicado: (2023)

Clinical utility of TSH receptor antibody levels in Graves’ orbitopathy: a comparison of two TSH receptor antibody immunoassays
por: Bluszcz, Gabriela A., et al.
Publicado: (2018)

A Case of Euthyroid Graves' Ophthalmopathy in a Patient Sero-Negative for TSH Receptor Autoantibody
por: Hotta, Asami, et al.
Publicado: (2018)

TSH receptor autoantibody levels post-total thyroidectomy in Graves’ ophthalmopathy: a meta-analysis
por: Anees, Arsalan, et al.
Publicado: (2023)

New-Generation Quantitative Immunoassays for SARS-CoV-2 Antibody Detection: Need for Harmonization
por: Villalta, Danilo, et al.
Publicado: (2022)

TSH receptor specific monoclonal autoantibody K1‐70(TM) targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy—Results from a phase I clinical trial
por: Furmaniak, Jadwiga, et al.
Publicado: (2022)

Novel immunoassay for TSH measurement in rats
por: Alves, Thalita G., et al.
Publicado: (2017)

Practical applications of studies on the TSH receptor and TSH receptor autoantibodies
por: Furmaniak, J., et al.
Publicado: (2020)

A patient with Graves’ disease showing only psychiatric symptoms and negativity for both TSH receptor autoantibody and thyroid stimulating antibody
por: Hamasaki, Hidetaka, et al.
Publicado: (2012)

Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
por: Bell, Lauren, et al.
Publicado: (2018)

In Graves’ disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features
por: Brancatella, A., et al.
Publicado: (2023)

Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' Disease
por: Paragliola, Rosa Maria, et al.
Publicado: (2019)

Clinical Usefulness of the Serological Gastric Biopsy for the Diagnosis of Chronic Autoimmune Gastritis
por: Antico, Antonio, et al.
Publicado: (2012)

Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022)

Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methods
por: D’Aurizio, F., et al.
Publicado: (2017)

Diagnostic Value of a Chimeric TSH Receptor (Mc4)-Based Bioassay for Graves' Disease
por: Lee, Ji In, et al.
Publicado: (2011)

TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy
por: Siderova, Mira, et al.
Publicado: (2018)

Correlation between TSH Receptor Antibody Assays and Clinical Manifestations of Graves' Orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2013)

Clinical Significance of Classification of Graves’ Disease According to the Characteristics of TSH Receptor Antibodies
por: Kim, Won Bae, et al.
Publicado: (2001)

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
por: Tansley, Sarah L, et al.
Publicado: (2020)

Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves’ Orbitopathy
por: Khamisi, Selwan, et al.
Publicado: (2023)

The value of FT4/TSH ratio in the differential diagnosis of Graves’ disease and subacute thyroiditis
por: Zhang, Yingjie, et al.
Publicado: (2023)

Bioassays for TSH Receptor Autoantibodies, from FRTL-5 Cells to TSH Receptor–LH/CG Receptor Chimeras: The Contribution of Leonard D. Kohn
por: Giuliani, Cesidio, et al.
Publicado: (2016)

Preclinical studies on the toxicology, pharmacokinetics and safety of K1-70(TM) a human monoclonal autoantibody to the TSH receptor with TSH antagonist activity
por: Furmaniak, Jadwiga, et al.
Publicado: (2019)

Receptor autoimmunity: diagnostic and therapeutic implications
por: Tozzoli, Renato
Publicado: (2020)

Comparative performance of ELISA and dot blot assay for TSH‐receptor antibody detection in Graves’ disease
por: Zulkarnain, Zulkarnain, et al.
Publicado: (2022)

FRI555 A Misdiagnosis Of TSH-secreting Adenoma With Thyrotoxicosis In A Patient With Graves’ Disease
por: Huynh, James, et al.
Publicado: (2023)

The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
por: Tansley, Sarah L., et al.
Publicado: (2020)

SAT-LB79 Biotin Depleting Procedure Does Not Impact the Reliability of TSH, LH and FSH Immunoassays
por: Gruson, Damien, et al.
Publicado: (2020)

Comparison of Five TSH-Receptor Antibody Assays in Graves’ disease: results from an observational pilot study
por: Struja, Tristan, et al.
Publicado: (2019)

OR18-03 Functional TSH Receptor Antibodies Are a Biomarker for Graves’ Disease - a Prospective Trial
por: Kahaly, George Jean, et al.
Publicado: (2020)

Detection of Genomic Structural Variants from Next-Generation Sequencing Data
por: Tattini, Lorenzo, et al.
Publicado: (2015)

Biological role of miR-204 and miR-211 in melanoma
por: Vitiello, Marianna, et al.
Publicado: (2018)

Videogaming Frequency and Executive Skills in Young Adults
por: Peracchia, Sara, et al.
Publicado: (2022)

Association between High Normal TSH Levels and Obesity in Women with Anti-Thyroid Autoantibodies (ATAs)
por: Velluzzi, Fernanda, et al.
Publicado: (2022)

Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
por: Cinquanta, Luigi, et al.
Publicado: (2017)

Serum TSH level as predictor of Graves’ disease recurrence following antithyroid drug withdrawal: A systematic review
por: Subekti, Imam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qtk1ogk721ljf7kamdoi748onn